Investee Company Update: Little Green Pharma Ltd
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SEED notes
SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, is pleased to note that its portfolio company, Little Green Pharma Ltd ('LGP'), has published its Half Year Report for the period ended 30 September 2023 on the ASX.
The Company owns 7,324,796 ordinary shares in LGP representing 2.44% of LGP's issued share capital.
Commenting on the results, Ed McDermott, Chief Executive Officer of SEED said: "As a shareholder in LGP, we are of course very disappointed in its share price performance, but we recognise the general market malaise in small caps. Equally, we are pleased and encouraged by LGP's operational performance and continued growth. During the period, LGP delivered a 40% increase in revenue to AU$12.8 million and positive EBITDA of AU$700,000. We believe LGP has a team of strong operators and look forward to updating shareholders on its developments."
LGP's Half Year Report and a recording of its Chief Executive Officer, Paul Long, discussing its Half Year financial results can be accessed at: https://investlittlegreenpharma.com/site/investor-centre/asx-announcements
About Little Green Pharma
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.